Live Breaking News & Updates on Prospective Clinical Trial Results

© 2021 Sight Sciences. All rights reserved.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. When used herein, words including “anticipate,” “will,” and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking. All forward-looking statements are based upon Sight Sciences’ current expectations and various assumptions. Actual results, levels of activity, performance, achievements and events could differ materially from those stated, anticipated or implied by such forward-looking statements. While the Company believes that its assumptions are reasonable, Sight Sciences may not realize its expectat ....

United States , Adam Bleeker , Interno Canaloplasty , Markf Pyfer , David Wirta , Markj Gallardo , Las Vegas , Arkadiy Yadgarov , Philip Taylor , Shay Smith , While The Company , American Society Of Cataract , Gilmartin Group , While Sight Sciences , Sight Sciences , Sight Sciences Inc , Surgical System , Refractive Surgery , Pacific Daylight Time , Pseudophakic Eyes , Minimally Invasive Glaucoma Surgery , Mild Moderate Open Angle Glaucoma , Prospective Multicenter Trial , Blink Assisted Meibomian Gland Procedure , Effective Treatment , Dry Eye ,